Handbook of Clinical medicine

75mg OD. Hydroxy- carbamide in high-risk patients. Myelofi brosis There is hyperplasia of megakaryocytes which produce platelet- derived growth factor, leading to intense marrow fi brosis and haematopoiesis in the spleen and livermassive hepatosplenomegaly. Presentation: Hypermetabolic symptoms: night sweats, fever, weight loss; abdominal discomfort due to spleno- megaly; bone marrow failure (Hb, infections, bleeding). Film: Leuko erythroblastic cells (nucleated red cells, p328); characteristic teardrop RBCS (see fi g 8.68). Hb. Bone marrow trephine for diagnosis (fi g 8.69). Treatment: Marrow support (see p364). Allogeneic stem cell transplant may be curative in young people but carries a high risk of mortality. Prognosis: Median survival 4–5 years. __OOHHCCMM__1100ee..iinnddbb 336666 0022//0055//22001177 1199::0077 ygolotameaH Causes of thrombocytosis 367 Platelets >450 ≈ 109/L may be a reactive phenomenon, seen with many conditions including: • Bleeding • Malignancy • Post-surgery • Infection • Trauma • Iron defi ciency • Chronic infl ammation, eg collagen disorders. Fig 8.67 Essential thrombocythaemia: many Fig 8.68 Teardrop cells, in myelofi brosis. platelets seen. © Dr Nivaldo Medeiros. © Prof. Christine Lawrence. Fig 8.69 Marrow trephine in myelo fi brosis: the streaming eff ect is caused by intense fi - brosis. Other causes of marrow fi brosis: any myeloprolife rative disorder,
